(Q34122524)

31 July 2017

1 reference

title

Beneficial effects of statins in coronary artery disease--beyond lowering cholesterol (English)

1 reference

31 July 2017

C G Sotiriou

1

1 reference

31 July 2017

J W Cheng

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Annals of Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

34

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

1432-1439

1 reference

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

31 July 2017

cites work

1 reference

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

21 January 2018

1 reference

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

The emerging concept of vascular remodeling

21 January 2018

1 reference

Atherosclerosis: an update

21 January 2018

1 reference

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

21 January 2018

1 reference

Pathophysiology of atherosclerosis

21 January 2018

1 reference

Antioxidants and atherosclerotic heart disease

21 January 2018

1 reference

Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics

21 January 2018

1 reference

Unmet therapeutic needs in the management of acute ischemia

21 January 2018

1 reference

Thrombosis and the pharmacology of antithrombotic agents

21 January 2018

1 reference

The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

21 January 2018

1 reference

Molecular and cellular biology of blood coagulation

21 January 2018

1 reference

Relation between coronary artery stenosis assessed by visual, caliper, and computer methods and exercise capacity in patients with single-vessel coronary artery disease. The Veterans Affairs ACME Investigators

21 January 2018

1 reference

Angiographic progression of coronary artery disease and the development of myocardial infarction

21 January 2018

1 reference

Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease

21 January 2018

1 reference

Clinical outcomes in statin treatment trials: a meta-analysis

21 January 2018

1 reference

Cholesterol reduction and the risk for stroke in men. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

Cholesterol lowering and endothelial function

21 January 2018

1 reference

Coronary Plaque Disruption

21 January 2018

1 reference

Statins do more than just lower cholesterol

21 January 2018

1 reference

Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein receptor activity in macrophages: in vitro and in vivo studies

21 January 2018

1 reference

Importance of endothelial function in mediating the benefits of lipid-lowering therapy.

21 January 2018

1 reference

The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression.

21 January 2018

1 reference

Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: in vitro and in vivo studies

21 January 2018

1 reference

Suppression of neointimal thickening by a newly developed HMG-CoA reductase inhibitor, BAYw6228, and its inhibitory effect on vascular smooth muscle cell growth

21 January 2018

1 reference

Assessment of effects of lipid-lowering drugs on hemostasis

21 January 2018

1 reference

Antiatherothrombotic properties of statins: implications for cardiovascular event reduction

21 January 2018

1 reference

Atorvastatin: an effective lipid-modifying agent in familial hypercholesterolemia

21 January 2018

1 reference

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

21 January 2018

1 reference

Effects of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.

21 January 2018

1 reference

Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.

21 January 2018

1 reference

Lovastatin Alters Blood Rheology in Primary Hyperlipoproteinemia: Dependence on Lipoprotein(a)?

21 January 2018

1 reference

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

21 January 2018

1 reference

Effect of Fluvastatin on Lipids and Fibrinolysis in Coronary Artery Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.10124

1 reference

31 July 2017

1 reference